SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Heiner Wedemeyer, EASL Recognition Awardee for 2014, Journal of Hepatology, 2014, 61, 3, 466

    CrossRef

  2. You have free access to this content2
    Geoffrey Dusheiko, Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues, Liver International, 2013, 33,
  3. 3
    Ulla Hellström, Magnus Lindh, Kim Krogsgaard, Staffan Sylvan, Demonstration of an association between detection of IgG antibody reactivity towards the C-terminal region of the preS1 protein of hepatitis B virus and the capacity to respond to interferon therapy in chronic hepatitis B, Journal of Gastroenterology and Hepatology, 2008, 23, 5
  4. 4
    Margarita Pardo, Javier Bartolomé, Vicente Carreño, Current Therapy of Chronic Hepatitis B, Archives of Medical Research, 2007, 38, 6, 661

    CrossRef

  5. 5
    Adrian Reuben, Prepared minds and the introduction of imaginon for hepatitic contagions, Hepatology, 2005, 41, 6
  6. 6
    Catherine Petruff Cheney, Sanjiv Chopra, Camilla Graham, HEPATITIS C, Infectious Disease Clinics of North America, 2000, 14, 3, 633

    CrossRef

  7. 7
    Z. J. Gong, S. De Meyer, C. Clarysse, C. Verslype, J. Neyts, E. De Clercq, S. H. Yap, Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro, Journal of Viral Hepatitis, 1999, 6, 3
    Direct Link:
  8. 8
    Kenji Ikeda, Satoshi Saitoh, Yoshiyuki Suzuki, Masahiro Kobayashi, Akihito Tsubota, Isao Koida, Yausji Arase, Mizuho Fukuda, Kazuaki Chayama, Naoya Murashima, Hiromitsu Kumada, Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients, Journal of Hepatology, 1998, 28, 6, 930

    CrossRef

  9. 9
    Isao Sakaida, Koichi Uchida, Yasuhiro Matsumura, Kiwamu Okita, Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-β1 expression in pig serum-induced rat liver fibrosis in vivo, Journal of Hepatology, 1998, 28, 3, 471

    CrossRef

  10. 10
    C. A. Lee, C. M. Kessler, D. Varon, U. Martinowitz, M. Heim, G. M. DUSHEIKO, Therapy for chronic hepatitis B and C infection in haemophilia, Haemophilia, 1998, 4, 4
  11. 11
    Michael A. Poles, Edward A. Lew, Douglas T. Dieterich, DIAGNOSIS AND TREATMENT OF HEPATIC DISEASE IN PATIENTS WITH HIV, Gastroenterology Clinics of North America, 1997, 26, 2, 291

    CrossRef

  12. 12
    Kenji Yamasaki, Jun-ichi Kira, Yoshio Koyanagi, Yuji Kawano, Naoko Miyano-Kurosaki, Minoru Nakamura, Eishi Baba, Jun Suzuki, Akifumi Yamamoto, Naoki Yamamoto, Takuro Kobayashi, Long term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological study, Journal of the Neurological Sciences, 1997, 147, 2, 135

    CrossRef

  13. 13
    R. Mateo, S. Jethmalani, D. C. Angus, J. Gorcsan, B. Uretsky, J. Fung, Interferon-associated left ventricular dysfunction in a liver transplant recipient, Digestive Diseases and Sciences, 1996, 41, 7, 1500

    CrossRef

  14. 14
    Y. Bayraktar, T. Koseoglu, C. Somner, B. Kayhan, A. Temizer, B. Uzunalimoglu, N. De Maria, D. H. Van Thiel, The use of deferoxamine infusions to enhance the response rate to interferon-α treatment of chronic viral hepatitis B, Journal of Viral Hepatitis, 1996, 3, 3
  15. 15
    Michael R. Narkewicz, Debra Smith, Arnold Silverman, John Vierling, Ronald J. Sokol, Clearance of chronic hepatitis B virus infection in young children after alpha interferon treatment, The Journal of Pediatrics, 1995, 127, 5, 815

    CrossRef

  16. 16
    ETSUKO ISONO, KATSUMI YAMAUCHI, IKUKO HARUTA, YUMIKO KAMOGAWA, NAOAKI HAYASHI, Effect of α-interferon on hepatitis B virus-specific cytotoxic T cells, Journal of Gastroenterology and Hepatology, 1995, 10, 1
  17. 17
    Pablo Muriel, Interferon-α preserves erythrocyte and hepatocyte atpase activities from liver damage induced by prolonged bile duct ligation in the rat, Journal of Applied Toxicology, 1995, 15, 6
  18. 18
    G Saracco, M Rizzetto, Recent results in the treatment of chronic B virus hepatitis, Biomedicine & Pharmacotherapy, 1995, 49, 2, 55

    CrossRef

  19. 19
    Mario G. Moreno, Pablo Muriel, Remission of liver fibrosis by interferon-α2b, Biochemical Pharmacology, 1995, 50, 4, 515

    CrossRef

  20. 20
    Geoffrey M. Dusheiko, Jennifer A. Roberts, Treatment of chronic type B and C hepatitis with interferon alfa: An economic appraisal, Hepatology, 1995, 22, 6
  21. 21
    Yuko Kawanishi, Norio Hayashi, Kazuhiro Katayama, Keiji Ueda, Tetsuo Takehara, Eiji Miyoshi, Eiji Mita, Akinori Kasahara, Hideyuki Fusamoto, Takenobu Kamada, Tumor necrosis factor-α and interferon-γ inhibit synergistically viral replication in hepatitis B virus-replicating cells, Journal of Medical Virology, 1995, 47, 3
  22. 22
    Jane W. S. Fang, P. C. WU, C. L. Lai, C. K. LO, Anthony Meager, Johnson Y. N. Lau, Hepatic expression of interferon-α in chronic hepatitis B virus infection, Digestive Diseases and Sciences, 1994, 39, 9, 2014

    CrossRef

  23. 23
    Helena M. Daniels, Alison O'Toole, Munther J. Hussein, Sergio Corridori, Graeme J.M. Alexander, Roger Williams, THFγ2 stimulates cytokine release by peripheral blood mononuclear cells of patients with chronic hepatitis B virus infection, Journal of Hepatology, 1994, 20, 3, 370

    CrossRef

  24. 24
    Patrick Marcellin, Jean-Pierre Benhamou, Treatment of chronic viral hepatitis, Baillière's Clinical Gastroenterology, 1994, 8, 2, 233

    CrossRef

  25. 25
    Tetsuya Ishikawa, Shinichi Kakumu, Kentaro Yoshioka, Susumu Kurokawa, Atsuhiko Kusakabe, Hirofumi Tahara, Hideo Hirofuji, Masami Kawabe, Effects of interferon-α treatment on hepatitis B virus antigen-specific immunologic responses in patients with chronic hepatitis B, Liver, 1993, 13, 2
  26. You have free access to this content26
    Toshikazu Uchida, Genetic Variations of the Hepatitis B Virus and Their Clinical Relevance, Microbiology and Immunology, 1993, 37, 6
  27. 27
    Toshikazu Uchida, Masaaki Taira, Toshio Shikata, Mitsuhiro Moriyama, Naohide Tanaka, Hitoshi Okubo, Yasuyuki Arakawa, Histological difference between complete responders and nonresponders to interferon therapy of the livers of patients with chronic hepatitis C, Pathology International, 1993, 43, 5
  28. 28
    Jean-Charles Ryff, To treat or not to treat?, Journal of Hepatology, 1993, 17, S42

    CrossRef

  29. 29
    H.R. Bruch, A. Korn, H. Klein, R. Markus, K. Malmus, R. Baumgarten, R. Müller, Treatment of chronic hepatitis B with interferon α-2b and interleukin-2, Journal of Hepatology, 1993, 17, S52

    CrossRef

  30. 30
    J. B. Braken, P. P. Koopmans, I. P. Van Munster, F. W. J. Gribnau, Current status of interferon alpha in the treatment of chronic hepatitis B, Pharmaceutisch Weekblad, 1992, 14, 4, 167

    CrossRef

  31. 31
    Keisuke Hamasaki, Keisuke Nakata, Kazuhiko Nakao, Satoru Mitsuoka, Takuya Tsutsumi, Yuji Kato, Masayoshi Shima, Nobuko Ishii, Taiki Tamaoki, Shigenobu Nagataki, Interaction of interferon-α with interleukin-1β or tumor necrosis factor-α on hepatitis B virus enhancer activity, Biochemical and Biophysical Research Communications, 1992, 183, 2, 904

    CrossRef

  32. 32
    Johnson Y.N. Lau, Alan G. Morris, Graeme J.M. Alexander, Roger Williams, Interferon-γ receptor expression in chronic hepatitis B virus infection, Journal of Hepatology, 1992, 14, 2-3, 294

    CrossRef

  33. 33
    Josefina Molina, Javier Bartolomé, Gloria Moraleda, Mercedes Ruiz-Moreno, Maria José Rua, Alberto Moreno, Vicente Carreno, Persistence of hepatitis B virus DNA after reduction of viral replication in serum and liver, Journal of Medical Virology, 1992, 38, 1
  34. 34
    Kimio Nishimura, Shigeaki Ishizaka, Tadasu Tsujii, Predictive indicators for the therapeutic effect of OK-432 in patients with chronic active type B hepatitis, Biotherapy, 1992, 4, 4, 299

    CrossRef

  35. 35
    Giovanna Fattovich, G. Giustina, F. Adami, Visceral leishmaniasis complicating chronic hepatitis B treated with interferon, Infection, 1992, 20, 5, 293

    CrossRef

  36. 36
    Johnson Y. N. Lau, C. L. Lai, P. C. Wu, H. T. Chung, Anna S. F. Lok, H. J. Lin, A randomised controlled trial of recombinant interferon-γ in chinese patients with chronic hepatitis B virus infection, Journal of Medical Virology, 1991, 34, 3
  37. 37
    G. M. DUSHEIKO, Alpha-interferon treatment of chronic hepatitis B infection: Predictors of responsiveness, Journal of Gastroenterology and Hepatology, 1991, 6, S1
  38. 38
    G. Fattovich, C. Betterle, L. Brollo, B. Pedini, G. Giustina, G. Realdi, A. Alberti, A. Ruol, Autoantibodies during α-interferon therapy for chronic hepatitis B, Journal of Medical Virology, 1991, 34, 2
  39. 39
    Pietro Lampertico, James S. Malter, Michael A. Gerber, Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics, Hepatology, 1991, 13, 3
  40. 40
    Johnson Y. N. Lau, Vincent G. Bain, Nikolai V. Naoumov, Heather M. Smith, Graeme J. M. Alexander, Roger Williams, Effect of interferon-γ on hepatitis B viral antigen expression in primary hepatocyte culture, Hepatology, 1991, 14, 6
  41. 41
    Fabio Tine', Silvio Magrin, Antonio Craxi', Luigi Pagliaro, Interferon for non-A, non-B chronic hepatitis, Journal of Hepatology, 1991, 13, 2, 192

    CrossRef

  42. 42
    Kohji Shibayama, Tatsufumi Nakamura, Kunihiko Nagasato, Susumu Shirabe, Mitsuhiro Tsujihata, Shigenobu Nagataki, Interferon-alpha treatment in HTLV-I-associated myelopathy, Journal of the Neurological Sciences, 1991, 106, 2, 186

    CrossRef

  43. 43
    Johnson Y. N. Lau, Nick Sheron, Alan G. Morris, Adrian B. Bomford, Graeme J. M. Alexander, Roger Williams, Interferon-α receptor expression and regulation in chronic hepatitis B virus infection, Hepatology, 1991, 13, 2
  44. 44
    Rainer Müller, Gundolf Gubernatis, Margarete Farle, Gabriele Niehoff, Heide Klein, Christian Wittekind, Günter Tusch, Hans-Ulrich Lautz, Klaus Böker, Walter Stangel, Rudolf Pichlmayr, Liver transplantation in HBs antigen (HBsAg) carriers, Journal of Hepatology, 1991, 13, 1, 90

    CrossRef

  45. 45
    Mercedes Ruiz-Moreno, Maria José Rua, Josefina Molina, Gloria Moraleda, Alberto Moreno, Jaime García-aguado, Vicente Carréño, Prospective, randomized controlled trial of interferon-α in children with chronic hepatitis B, Hepatology, 1991, 13, 6
  46. 46
    Pierre Brissot, Christian Jacquelinet, Hervé Jouanolle, Véronique David, Dominique Guyader, Monique Guéguen, Martine Blayau, Gérard Lescoat, Michel Messner, Yves Deugnier, Short-term prednisolone followed by recombinant human α-interferon alone or combined with adenine-arabinoside in chronic hepatitis B, Journal of Hepatology, 1991, 12, 2, 181

    CrossRef

  47. 47
    R. Guan, H. S. Ng, I. Yap, S. F. Leong, C. B. Colby, A. Wee, J. Ho, L. H. Tan, R. Smith, Treatment of Chronic Hepatitis B Virus Infection Using a Mutant Recombinant Human β-Interferon, Drug Investigation, 1991, 3, 2, 82

    CrossRef

  48. 48
    S. B. Sinclair, G. A. Levy, Treatment of fulminant viral hepatic failure with prostaglandin E, Digestive Diseases and Sciences, 1991, 36, 6, 791

    CrossRef

  49. 49
    A prospective trial of recombinant human interferon alpha 2B in previously untreated patients with hepatocellular carcinoma, Cancer, 1990, 66, 1
  50. 50
    J.L.Garcia de Ancos, J.A. Roberts, G.M. Dusheiko, An economic evaluation of the costs of α-interferon treatment of chronic active hepatitis due to hepatitis B or C virus, Journal of Hepatology, 1990, 11, S11

    CrossRef

  51. 51
    Shinya Nakajima, Tetsuo Kuroki, Machiko Shintani, Osamu Kurai, Tadashi Takeda, Shuhei Nishiguchi, Susumu Shiomi, Shuichi Seki, Kenzo Kobayashi, Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon, Hepatology, 1990, 12, 6
  52. 52
    Kiyoshi Takeda, Yoshihiro Akahane, Hiroshi Suzuki, Hiroaki Okamoto, Fumio Tsuda, Yuzo Miyakawa, Makoto Mayumi, Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy, Hepatology, 1990, 12, 6
  53. 53
    J. Fevery, A. Elewaut, P. Michielsen, F. Nevens, P. Van Eyken, M. Adler, V. Desmet, Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study, Journal of Hepatology, 1990, 11, S108

    CrossRef

  54. 54
    Anna Suk-Fong Lok, Ching-Lung Lai, Elsie Kit-Yee Leung, Interferon antibodies may negate the antiviral effects of recombinant α-interferon treatment in patients with chronic hepatitis B virus infection, Hepatology, 1990, 12, 6
  55. 55
    J.-P. Coppens, C. Cornu, E. Lens, M. Lamy, A.P. Geubel, Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a long-term follow-up study, Journal of Hepatology, 1990, 11, S126

    CrossRef

  56. 56
    H. Hofmann, W. Tuma, F.X. Heinz, C. Kunz, Relevance of Hepatitis B DNA Detection in Patient's Serum, Zentralblatt für Bakteriologie, 1990, 272, 4, 485

    CrossRef

  57. You have free access to this content57
    Y. K. YOO, J. B. GAVALER, K. CHEN, T. L. WHITESIDE, D. H. THIEL, The effect of recombinant interferon-alpha on lymphocyte subpopulations and HLA-DR expression on liver tissue of HBV-positive individuals, Clinical & Experimental Immunology, 1990, 82, 2
  58. 58
    A.M. Di Bisceglie, P. Martin, M. Lisker-Melman, C. Kassianides, J. Korenman, N.V. Bergasa, B. Baker, J.H. Hoofnagle, Therapy of chronic delta hepatitis with interferon alfa-2b, Journal of Hepatology, 1990, 11, S151

    CrossRef

  59. 59
    Adrian M. Di Bisceglie, Vinod K. Rustgi, Chris Kassianides, Mauricio Lisker-Melman, Yoon Park, Jeanne G. Waggoner, Jay H. Hoofnagle, Therapy of chronic hepatitis b with recombinant human alpha and gamma interferon, Hepatology, 1990, 11, 2
  60. 60
    R. Müller, R. Baumgarten, R. Markus, M. Schulz, H. Wittenberg, B. Hintsche-Kilger, J.-D. Fengler, P. Von Wussow, H. Meisel, H. Klein, K. Malmus, F.W. Schmidt, Treatment of chronic hepatitis B with interferon alfa-2b, Journal of Hepatology, 1990, 11, S137

    CrossRef

  61. 61
    J.H. Hoofnagle, α-Interferon therapy of chronic hepatitis B. Current status and recommendations, Journal of Hepatology, 1990, 11, S100

    CrossRef

  62. 62
    A.S.F. Lok, C.L. Lai, P.C. Wu, J.Y.N. Lau, E.K.Y. Leung, L.S.K. Wong, Y.L. Fung, α-Interferon treatment in Chinese patients with chronic hepatitis B, Journal of Hepatology, 1990, 11, S121

    CrossRef

  63. 63
    V. G. Bain, H. M. Daniels, A. Chanas, G. J. M. Alexander, Roger Williams, Foscarnet therapy in chronic hepatitis B virus e antigen carriers, Journal of Medical Virology, 1989, 29, 2
  64. 64
    Giovanna Fattovich, Lucio Brollo, Stefania Boscaro, Patrizia Pontisso, Giuliano Giustina, Domenico Criscuolo, Dionigi Maladorno, Alfredo Alberti, Giuseppe Realdi, Arturo Ruol, Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis B, Journal of Hepatology, 1989, 9, 3, 331

    CrossRef

  65. 65
    Maurizia Rossana Brunetto, Filippo Oliveri, Giuseppe Rocca, Domenico Criscuolo, Elisabetta Chiaberge, Maria Capalbo, Ezio David, Giorgio Verme, Ferruccio Bonino, Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen, Hepatology, 1989, 10, 2
  66. 66
    Jean-Pierre Coppens, Chantal Cornu, Emile Lens, Monique Lamy, Andre Geubel, Prospective trial of recombinant leucocyte interferon in chronic hepatitis B: a 10-month follow-up study, Liver, 1989, 9, 5
  67. 67
    Stephen J. Williams, Geoffrey C. Farrell, Serial antipyrine clearance studies detect altered hepatic metabolic function during spontaneous and interferon-induced changes in chronic hepatitis B disease activity, Hepatology, 1989, 10, 2
  68. 68
    Graeme Alexander, Treatment of acute and chronic viral hepatitis, Baillière's Clinical Gastroenterology, 1989, 3, 1, 1

    CrossRef

  69. 69
    Juan Carlos Porres, Vicente Carreño, Javier Bartolomé, Alberto Moreno, Fernando Galiana, Juan Antonio Quiroga, Treatment of chronic delta infection with recombinant human interferon alpha 2c at high doses, Journal of Hepatology, 1989, 9, 3, 338

    CrossRef

  70. 70
    Georg Hess, Siegbert Rossol, Rita Voth, Christian Weber, Norbert Drees, Karl-Hermann Meyer zum Büscheafelde, Treatment of protracted acute type B hepatitis with recombinant α-A-interferon, Journal of Hepatology, 1989, 8, 1, 73

    CrossRef

  71. 71
    R.A. de Man, J. Lindemans, S.W. Schalm, F.J.W. ten Kate, β2-Microglobulin and antiviral therapy for chronic hepatitis type B, Antiviral Research, 1989, 11, 4, 181

    CrossRef

  72. 72
    Mark J. Czaja, Francis R. Weiner, Shizuko Takahashi, Marie-Adele Giambrone, Peter H. Der Van Meide, Huub Schellekens, Luis Biempica, Mark A. Zern, γ-interferon treatment inhibits collagen deposition in murine schistosomiasis, Hepatology, 1989, 10, 5
  73. 73
    John A. Payne, Chronic hepatitis: Pathogenesis and treatment, Disease-a-Month, 1988, 34, 3, 113

    CrossRef

  74. 74
    Javier Brahm, Graeme J. M. Alexander, Elizabeth A. Fagan, Heather M. Smith, Helena M. Daniels, Adrian L. W. F. Eddleston, Roger Williams, Clearance of pre-S2 antigen: A marker of successful interferon therapy in hepatitis B virus infection, Journal of Medical Virology, 1988, 24, 4
  75. 75
    AnnaS.F. Lok, Pui-Chee Wu, Ching-Lung Lai, ElsieK.Y. Leung, LONG-TERM FOLLOW-UP IN A RANDOMISED CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE PATIENTS WITH CHRONIC HEPATITIS B INFECTION, The Lancet, 1988, 332, 8606, 298

    CrossRef

  76. 76
    Stephanos J. Hadziyannis, Lymphoblastoid interferon in controlled trials of chronic hepatitis B virus infection, Hepatology, 1988, 8, 3
  77. 77
    Michiko Shindo, Tadao Okuno, Masayuki Matsumoto, Makoto Takeda, Tatsuro Takino, Junko Sokawa, Akira Iwata, Yoshihiro Sokawa, Serum 2′,5′-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis B, Hepatology, 1988, 8, 2
  78. 78
    KIYOHIKO KURAI, SHIRO IINO, KAZUHIKO KOIKE, KEIJI MITAMURA, YASUO ENDO, HIROSHI OKA, The effects of antiviral agents on serum hepatitis B e antigen levels in chronic type B hepatitis, Journal of Gastroenterology and Hepatology, 1988, 3, 2
  79. 79
    Koichi Kanai, Satoshi Morioka, Takeyuki Nakajima, Hidemasa Ishii, Katsutoshi Tamakoshi, Hiroko Matsuda, Masahiro Matsumoto, Noriaki Mizushima, Yasunori Takehira, Treatment of chronic hepatitis B with recombinant leukocyte interferon and cyanidanol, Gastroenterologia Japonica, 1988, 23, 1, 44

    CrossRef

  80. 80
    V. Carreño, J.C. Porres, I. Mora, J. Gutiez, J.A. Quiroga, S.Ramón y Cajal, H. Oliva, C. Compernolle, J. Bartolomé, A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules, Antiviral Research, 1987, 8, 3, 125

    CrossRef

  81. 81
    R.A. Heijtink, P. Smal, F.J. ten Kate, J. Kruining, S.W. Schalm, Detection of HBV-DNA in liver biopsy and serum: Its significance in the selection of hepatitis B patients for antiviral therapy, Antiviral Research, 1987, 7, 6, 329

    CrossRef

  82. 82
    Ching-Lung Lai, Hsiang-Ju Lin, Eng-Kiong Yeoh, Anna Suk-Fong Lok, Pui-Chee Wu, Chap-Yung Yeung, PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN, The Lancet, 1987, 330, 8564, 877

    CrossRef

  83. 83
    Vicente Carreño, Juan C. Porres, Ignacio Mora, Javier Bartolomé, Caridad Bas, Julia Gutiez, José Cortés, Carlos Hernández Guio, Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon, Liver, 1987, 7, 6
  84. 84
    A. Franco, V. Barnaba, M. Levrero, G. Ruberti, A. Van Dyke, M.S. Bonavita, F. Balsano, Effect of 28 consecutive days lymphoblastoid interferon (α-IFN) administration on hepatitis B virus related chronic liver disease, Journal of Hepatology, 1986, 3, S239

    CrossRef

  85. 85
    L.J. Scully, A.M.L. Lever, I. Yap, M. Pignatelli, H.C. Thomas, Identification of factors influencing response rate to antiviral therapy of chronic hepatitis B virus infection, Journal of Hepatology, 1986, 3, S291

    CrossRef

  86. 86
    Gary L. Davis, Jay H. Hoofnagle, Interferon in viral hepatitis: Role in pathogenesis and treatment, Hepatology, 1986, 6, 5
  87. 87
    M.G. Anderson, T.J. Harrison, G.J.M. Alexander, A.J. Zuckerman, I.M. Murray-Lyon, Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B, Journal of Hepatology, 1986, 3, S225

    CrossRef

  88. 88
    G.M. Dusheiko, A.C. Paterson, L. Pitcher, C. Kassianides, A.M. DiBisceglie, E. Song, M.C. Kew, Recombinant leucocyte interferon treatment of chronic hepatitis B, Journal of Hepatology, 1986, 3, S199

    CrossRef

  89. 89
    C. Trépo, D. Ouzan, T. Fontanges, M. Chevallier, P. Chossegros, F. Degos, P. Chevallier, O. Hantz, Therapeutic potential of acyclovir and of the interferons in HBV-related chronic active hepatitis due to HBV with or without HDV superinfection, Journal of Hepatology, 1986, 3, S129

    CrossRef

  90. 90
    Jay H. Hoofnagle, Kevin D. Mullen, D. Brian Jones, Vinod Rustgi, Adrian Di Bisceglie, Marion Peters, Jeanne G. Waggoner, Yoon Park, E. Anthony Jones, Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon, New England Journal of Medicine, 1986, 315, 25, 1575

    CrossRef

  91. 91
    Sheila Sherlock, HowardC. Thomas, TREATMENT OF CHRONIC HEPATITIS DUE TO HEPATITIS B VIRUS, The Lancet, 1985, 326, 8468, 1343

    CrossRef

  92. 92
    Martin Thyge Mellerup, Kim Krogsgaard, Christian Gluud, Glucocorticosteroids for viral hepatitis B, The Cochrane Library,